Metabolism of the contraceptive steroid desogestrel by human liver in vitro

Journal of Steroid Biochemistry

Volumn 35, Issue 2, 1990, Pages 281-288

  Madden, S ^a   Back, D J ^a   Orme, M L'E ^a  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3ALPHA HYDROXYSTEROID DEHYDROGENASE; CIMETIDINE; DESOGESTREL; LEVONORGESTREL; PRIMAQUINE; TRILOSTANE;

ARTICLE; DRUG METABOLISM; HUMAN; HUMAN CELL; LIVER; PRIORITY JOURNAL; STEROID METABOLISM;

BIOLOGY; CLINICAL RESEARCH; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS, PROGESTIN--PHARMACODYNAMICS; CONTRACEPTIVE AGENTS--PHARMACODYNAMICS; EXAMINATIONS AND DIAGNOSES; FAMILY PLANNING; HEPATIC EFFECTS; IN VITRO; LABORATORY EXAMINATIONS AND DIAGNOSES; METABOLIC EFFECTS; PHYSIOLOGY; RESEARCH METHODOLOGY; STEROID METABOLIC EFFECTS;

ADOLESCENT; ADULT; AGED; CHEMISTRY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DESOGESTREL; ETHINYL ESTRADIOL; FEMALE; HUMAN; IN VITRO; MALE; MICONAZOLE; MICROSOMES, LIVER; MIDDLE AGE; NORPREGNENES; OXIDATIVE PHOSPHORYLATION COUPLING FACTORS; PRIMAQUINE; PROGESTATIONAL HORMONES, SYNTHETIC; STANOLONE;

EID: 0025135546     PISSN: 00224731     EISSN: None     Source Type: Journal    
DOI: 10.1016/0022-4731(90)90285-Z     Document Type: Article

References (26)

1. Biological effects of a new and potent progestogen. A clinical study
2. Plasma concentrations of 3-keto desogestrel after oral administration of desogestrel and intravenous administration of 3-keto desogestrel
3. Metabolism of the contraceptive steroid desogestrel by the intestinal mucosa
4. Metabolism of a new synthetic progestagen, Org 2969, by human liver in vitro
5. The carbon monoxide binding pigment of liver microsomes
6. Protein measurement with the folin phenol reagent
7. The determination of enzyme inhibitor constants
8. Serum levels of 3-keto desogestrel after oral administration of desogestrel and 3-keto desogestrel
9. Genetic variation in the human cytochrome P-450 system
10. Variability in drug metabolism: importance of genetic constitution
11. Environmental factors affecting drug metabolism
12. Interactions of hepatic cytochromes P-450 with steroid hormones
13. Multiplicity of mammalian microsomal cytochromes P-450
14. Comparison of monoxygenase activities and cytochrome P-450 isozyme concentrations in human liver microsome
15. Metabolism of lynestrenol: characterization of 3-hydroxylation using rabbit liver microsomes in vitro
16. 14C Norgestrel in man
17. Excretion and stereoselective biotransformations of dl-, d- and l-norgestrel in women
18. In vitro inhibition studies of tolbutamide hydroxylase activity of human liver microsomes by azoles, sulphonamides and quinolines
19. The metabolism of 17α-ethinyloestradiol by human liver microsomes: formation of catechol and chemically reactive metabolites
20. Mechanistic aspects of the inhibition of microsomal drug oxidation by primaquine
21. Mechanisms of the inhibition of cytochrome P-450 mediated drug oxidation by therapeutic agents
22. Antagonistic action of estrogens, flutamide and human growth hormone on androgen-induced changes in the activities of some enzymes of hepatic steroid metabolism in the rat
23. Inhibition of human placental progesterone synthesis and aromatase activity by synthetic steroidogenic inhibitors in vitro
24. Inhibition of ovarian, placental, and adrenal steroidogenesis in the rhesus monkey by trilostane
25. Trilostane, an orally active inhibitor of steroid biosynthesis
26. Regulation of steroid-transforming enzymes by endogenous steroids